Key result
In a 39-year-old man with pre-excited atrial fibrillation, Wolff-Parkinson-White syndrome, and Ebstein's anomaly who declined ablation, amiodarone successfully restored and maintained sinus rhythm.
Why the study?
There was no suggestion of pharmacologic management for pre-excited atrial fibrillation in Ebstein's anomaly if the patient declines surgical or catheter ablation therapy.
Does amiodarone improve rhythm control in a patient with pre-excited atrial fibrillation and Ebstein's anomaly?
Case Report (n=1)
Does amiodarone improve rhythm control in a patient with pre-excited atrial fibrillation and Ebstein's anomaly?
Amiodarone may serve as a viable pharmacological alternative for managing pre-excited atrial fibrillation in patients with Ebstein's anomaly who decline ablation therapy.
Answers are grounded in this paper and cite their sources.
Suggests a potential alternative when ablation is refused in complex congenital pre-excited AF;.
This is a case report of a 39-year-old man who presented to the emergency room with atrial fibrillation (AF), pre-excitation, and Ebstein's anomaly (EA). Currently, there was no suggestion of pharmacologic management if the patient declines surgical or catheter ablation therapy. A review of the literature concluded that amiodarone may be a suitable therapy for the pharmacological management of this patient.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2021) conducted a case report in Pre-excited Atrial Fibrillation, Wolff-Parkinson-White syndrome, and Ebstein's Anomaly (n=1). Amiodarone was evaluated on Arrhythmia recovery and maintenance of sinus rhythm. In a 39-year-old man with pre-excited atrial fibrillation, Wolff-Parkinson-White syndrome, and Ebstein's anomaly who declined ablation, amiodarone successfully restored and maintained sinus rhythm.
Synapse has enriched 10 related papers. Consider them for comparative context: